Cancer premiums and latency effects: A risk tradeoff approach for valuing reductions in fatal cancer risks (Q928723): Difference between revisions
From MaRDI portal
Latest revision as of 11:46, 28 June 2024
scientific article
Language | Label | Description | Also known as |
---|---|---|---|
English | Cancer premiums and latency effects: A risk tradeoff approach for valuing reductions in fatal cancer risks |
scientific article |
Statements
Cancer premiums and latency effects: A risk tradeoff approach for valuing reductions in fatal cancer risks (English)
0 references
11 June 2008
0 references
Value of statistical life
0 references
Cancer risk
0 references
Risk trade-off
0 references
Latency
0 references